Fred Hutchinson Cancer Research Center has selected GenoLogics to develop an integrated biorepository and biomedical informatics software solution for the centre’s Translational and Outcomes Research group.
The GenoLogics software is being provided to Fred Hutchinson Cancer Research Center by the Canary Foundation, a non-profit, tax exempt public charity committed to the development of early-detection tests for solid-tumour cancers.
Fred Hutchinson Cancer Research Center focuses on discovering new ways to detect cancers earlier, developing effective treatments with fewer side effects and learning how to prevent cancers from growing in the first place. To connect the clinical and discovery research processes, the center pursues translational research under its Translational and Outcomes Research group.
‘To assist with realising our vision for translational research, we needed a suite of informatics solutions that enables us to work seamlessly with clinical and laboratory researchers, as well as patients and healthy individuals,’ said Dr Nicole Urban, head of the Translational and Outcomes Research group. ‘Given the importance of collecting the clinical information to achieve this vision, we decided to work with a commercial vendor to provide our biomedical informatics solution. GenoLogics not only has a collaborative approach to developing a solution for us, but our visions around translational research are highly synergistic.’
GenoLogics launched its biomedical informatics software solution to address the needs of translational research initiatives to track observational studies, collect patient data at remote sites, provide biospecimen and clinical annotations management and facilitate researchers querying on clinical information and requesting samples. The suite is comprised of five integrated products: BioVault for biospecimen management; BioChronicle for clinical annotations management; BioQuest to enable Web access; BioSphere for study management; and BioSource to enable electronic patient questionnaires.
